This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Anguissola G, Leu D, Simonetti GD, Simonetti BG, Lava SAG, Milani GP, Bianchetti MG, Scoglio M. Kidney tubular injury induced by valproic acid: systematic literature review. Pediatr Nephrol 2023;38:1725–31. doi: 10.1007/s00467-022-05869-8AnguissolaGLeuDSimonettiGDSimonettiBGLavaSAGMilaniGPBianchettiMGScoglioM. Kidney tubular injury induced by valproic acid: systematic literature review. Pediatr Nephrol2023;38:1725–31. doi: 10.1007/s00467-022-05869-8Open DOISearch in Google Scholar
Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact 2017;17:303–6. PMCID: PMC5749037KaratzasAParidisDKozyrakisDTzortzisVSamarinasMDailianaZKarachaliosT. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact2017;17:303–6. PMCID: PMC5749037Search in Google Scholar
Heidari R, Jafari F, Khodaei F, ShiraziYeganeh B, Niknahad H. Mechanism of valproic acid induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology 2018; 23:351–61. doi: 10.1111/nep.13012HeidariRJafariFKhodaeiFShiraziYeganehBNiknahadH. Mechanism of valproic acid induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology2018; 23:351–61. doi: 10.1111/nep.13012Open DOISearch in Google Scholar
Ono H. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation. Clin Exp Nephrol 2019;23:148–9. doi: 10.1007/s10157-018-1581-3OnoH. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation. Clin Exp Nephrol2019;23:148–9. doi: 10.1007/s10157-018-1581-3Open DOISearch in Google Scholar
Gezginci-Oktayoglu S, Turkyilmaz IB, Ercin M, Yanardag R, Bolkent S. Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties. Protoplasma 2016;253:127–35. doi: 10.1007/s00709-015-0796-3Gezginci-OktayogluSTurkyilmazIBErcinMYanardagRBolkentS. Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties. Protoplasma2016;253:127–35. doi: 10.1007/s00709-015-0796-3Open DOISearch in Google Scholar
El-Shenawy NS, Hamza RZ. Nephrotoxicity of sodium valproate and protective role of L-cysteine in rats at biochemical and histological levels. J Basic Clin Physiol Pharmacol 2016;27:497–504. doi: 10.1515/jbcpp-2015-0106El-ShenawyNSHamzaRZ. Nephrotoxicity of sodium valproate and protective role of L-cysteine in rats at biochemical and histological levels. J Basic Clin Physiol Pharmacol2016;27:497–504. doi: 10.1515/jbcpp-2015-0106Open DOISearch in Google Scholar
Chaudhary S, Ganjoo P, Raiusddin S, Parvez S. Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid. Protoplasma 2015;252:209–17. doi: 10.1007/s00709-014-0670-8ChaudharySGanjooPRaiusddinSParvezS. Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid. Protoplasma2015;252:209–17. doi: 10.1007/s00709-014-0670-8Open DOISearch in Google Scholar
Koroglu OF, Gunata M, Vardi N, Yildiz A, Ates B, Colak C, Tanriverdi LH, Parlakpinar H. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats. Tissue Cell 2021;72:101526. doi: 10.1016/j.tice.2021.101526KorogluOFGunataMVardiNYildizAAtesBColakCTanriverdiLHParlakpinarH. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats. Tissue Cell2021;72:101526. doi:10.1016/j.tice.2021.101526Open DOISearch in Google Scholar
Jutrić D, Đikić D, Boroš A, Odeh D, Drozdek SD, Gračan R, Dragičević P, Crnić I, Jurčević IL. Effects of naringin and valproate interaction on liver steatosis and dyslipidaemia parameters in male C57BL6 mice. Arh Hig Rada Toksikol 2022;73:71–82. doi: 10.2478/aiht-2022-73-3608JutrićDĐikićDBorošAOdehDDrozdekSDGračanRDragičevićPCrnićIJurčevićIL. Effects of naringin and valproate interaction on liver steatosis and dyslipidaemia parameters in male C57BL6 mice. Arh Hig Rada Toksikol2022;73:71–82. doi: 10.2478/aiht-2022-73-3608Open DOISearch in Google Scholar
Stabrauskiene J, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines 2022;10:1686. doi: 10.3390/biomedicines10071686StabrauskieneJKopustinskieneDMLazauskasRBernatonieneJ. Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines2022;10:1686. doi:10.3390/biomedicines10071686Open DOISearch in Google Scholar
Amini N, Maleki M, Badavi M. Nephroprotective activity of naringin against chemical-induced toxicity and renal ischemia/reperfusion injury: A review. Avicenna J Phytomed 2022;12:357–70. doi: 10.22038/AJP.2022.19620AminiNMalekiMBadaviM. Nephroprotective activity of naringin against chemical-induced toxicity and renal ischemia/reperfusion injury: A review. Avicenna J Phytomed2022;12:357–70. doi: 10.22038/AJP.2022.19620Open DOISearch in Google Scholar
Wang R, Wu G, Dai T, Lang Y, Chi Z, Yang S, Dong D. Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation. Exp Ther Med 2021;21:66. doi: 10.3892/etm.2020.9498WangRWuGDaiTLangYChiZYangSDongD. Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation. Exp Ther Med2021;21:66. doi:10.3892/etm.2020.9498Open DOISearch in Google Scholar
Elsawy H, Alzahrani AM, Alfwuaires M, Abdel-Moneim AM, Khalil M. Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats. Biomed Pharmacother 2021;143:112180. doi: 10.1016/j.biopha.2021.112180ElsawyHAlzahraniAMAlfwuairesMAbdel-MoneimAMKhalilM. Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats. Biomed Pharmacother2021;143:112180. doi:10.1016/j.biopha.2021.112180Open DOISearch in Google Scholar
Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): National Academies Press; 2011.Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. 8th ed.Washington (DC): National Academies Press; 2011.Search in Google Scholar
Landeka Jurčević I, Dora M, Guberović I, Petras M, Rimac S, Brnčić, Đikić D. Polyphenols from wine lees as a novel functional bioactive compound in the protection against oxidative stress and hyperlipidaemia. Food Technol Biotechnol 2017;55:109–16. doi: 10.17113/ftb.55.01.17.4894Landeka JurčevićIDoraMGuberovićIPetrasMRimacSBrnčićĐikićD. Polyphenols from wine lees as a novel functional bioactive compound in the protection against oxidative stress and hyperlipidaemia. Food Technol Biotechnol2017;55:109–16. doi: 10.17113/ftb.55.01.17.4894Open DOISearch in Google Scholar
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75. doi: 10.1016/S0021-9258(19)52451-6LowryOHRosebroughNJFarrALRandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951;193:265–75. doi: 10.1016/S0021-9258(19)52451-6Open DOISearch in Google Scholar
Flohé L, Ötting F. Superoxide dismutase assays. Meth Enzymol 1984;105:93–104. doi: 10.1016/s0076-6879(84)05013-8FlohéLÖttingF. Superoxide dismutase assays. Meth Enzymol1984;105:93–104. doi: 10.1016/s0076-6879(84)05013-8Open DOISearch in Google Scholar
Aebi H. Catalase in vitro. Meth Enzymol 1984;105:121–6. doi: 10.1016/s0076-6879(84)05016-3AebiH. Catalase in vitro. Meth Enzymol1984;105:121–6. doi: 10.1016/s0076-6879(84)05016-3Open DOISearch in Google Scholar
Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem 2003;312:224–7. doi: 10.1016/s0003-2697(02)00506-7EyerPWorekFKiderlenDSinkoGStuglinASimeon-RudolfVReinerE. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem2003;312:224–7. doi: 10.1016/s0003-2697(02)00506-7Open DOISearch in Google Scholar
Pirahanchi Y, Jessu R, Aeddula NR. Physiology, sodium potassium pump. Treasure Island (FL). StatPearls Publishing; 2022.PirahanchiYJessuRAeddulaNR. Physiology, sodium potassium pump. Treasure Island (FL). StatPearls Publishing; 2022.Search in Google Scholar
White KE, Gesek FA, Nesbitt T, Drezner MK, Friedman PA. Molecular dissection of Ca2+ efflux in immortalized proximal tubule cells. J Gen Physiol 1997;109:217–28. doi: 10.1085/jgp.109.2.217WhiteKEGesekFANesbittTDreznerMKFriedmanPA. Molecular dissection of Ca2+ efflux in immortalized proximal tubule cells. J Gen Physiol1997;109:217–28. doi: 10.1085/jgp.109.2.217Open DOISearch in Google Scholar
Curry JN, Yu ASL. Paracellular calcium transport in the proximal tubule and the formation of kidney stones. Am J Physiol Renal Physiol 2019;316:966–9. doi: 10.1152/ajprenal.00519.2018CurryJNYuASL. Paracellular calcium transport in the proximal tubule and the formation of kidney stones. Am J Physiol Renal Physiol2019;316:966–9. doi: 10.1152/ajprenal.00519.2018Open DOISearch in Google Scholar
Gumz ML, Lynch IJ, Greenlee MM, Cain BD, Wingo CS. The renal H+-K+-ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol 2010;298:12–21. doi: 10.1152/ajprenal.90723.2008GumzMLLynchIJGreenleeMMCainBDWingoCS. The renal H+-K+-ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol2010;298:12–21. doi: 10.1152/ajprenal.90723.2008Open DOISearch in Google Scholar
Đikić D, Jutrić D, Dominko K. The dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer’s disease. SEEMEDJ 2017;1:74–89. doi: 10.26332/seemedj.v1i1.26ĐikićDJutrićDDominkoK. The dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer’s disease. SEEMEDJ2017;1:74–89. doi: 10.26332/seemedj.v1i1.26Open DOISearch in Google Scholar
Monostory K, Nagy A, Tóth K, Bűdi T, Kiss Á, Déri M, Csukly G. Relevance of CYP2C9 function in valproate therapy. Curr Neuropharmacol 2019;17:99–106. doi: 10.2174/1570159X15666171109143654MonostoryKNagyATóthKBűdiTKissÁDériMCsuklyG. Relevance of CYP2C9 function in valproate therapy. Curr Neuropharmacol2019;17:99–106. doi: 10.2174/1570159X15666171109143654Open DOISearch in Google Scholar
Knights KM, Rowland A, Miners JO. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol 2013;76:587–602. doi: 10.1111/bcp.12086KnightsKMRowlandAMinersJO. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol2013;76:587–602. doi: 10.1111/bcp.12086Open DOISearch in Google Scholar
Ding S, Qiu H, Huang J, Chen R, Zhang J, Huang B, Zou X, Cheng O, Jiang Q. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy. Chem Biol Interact 2019;307:116–24. doi: 10.1016/j.cbi.2019.05.004DingSQiuHHuangJChenRZhangJHuangBZouXChengOJiangQ. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy. Chem Biol Interact2019;307:116–24. doi: 10.1016/j.cbi.2019.05.004Open DOISearch in Google Scholar
Oyagbemi AA, Omobowale TO, Adejumobi OA, Owolabi AM, Ogunpolu BS, Falayi OO, Hassan FO, Ogunmiluyi IO, Asenuga ER, Ola-Davies OE, Soetan KO, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Oguntibeju OO, Yakubu MA. Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/kidney injury molecule (Kim-1) signaling pathway. Eur J Pharmacol 2020;880:173142. doi: 10.1016/j.ejphar.2020.173142OyagbemiAAOmobowaleTOAdejumobiOAOwolabiAMOgunpoluBSFalayiOOHassanFOOgunmiluyiIOAsenugaEROla-DaviesOESoetanKOSabaABAdedapoAANkadimengSMMcGawLJOguntibejuOOYakubuMA. Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/angiotensin converting enzyme (ACE)/kidney injury molecule (Kim-1) signaling pathway. Eur J Pharmacol2020;880:173142. doi:10.1016/j.ejphar.2020.173142Open DOISearch in Google Scholar
Amudha K, Pari L. Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chem Biol Interact 2011;193:57–64. doi: 10.1016/j.cbi.2011.05.003AmudhaKPariL. Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chem Biol Interact2011;193:57–64. doi: 10.1016/j.cbi.2011.05.003Open DOISearch in Google Scholar
Caglayan C, Temel Y, Kandemir FM, Yildirim S, Kucukler S. Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage. Environ Sci Pollut Res Int 2018;25:20968–84. doi: 10.1007/s11356-018-2242-5CaglayanCTemelYKandemirFMYildirimSKucuklerS. Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage. Environ Sci Pollut Res Int2018;25:20968–84. doi: 10.1007/s11356-018-2242-5Open DOISearch in Google Scholar
Singh D, Chander V, Chopra K. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology 2004;201:143–51. doi: 10.1016/j.tox.2004.04.018SinghDChanderVChopraK. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology2004;201:143–51. doi: 10.1016/j.tox.2004.04.018Open DOISearch in Google Scholar
Amini N, Sarkaki A, Dianat M, Mard SA, Ahangarpour A, Badavi M. The renoprotective effects of naringin and trimetazidine on renal ischemia/ reperfusion injury in rats through inhibition of apoptosis and downregulation of micoRNA-10a. Biomed Pharmacother 2019;112:108568. doi: 10.1016/j.biopha.2019.01.029AminiNSarkakiADianatMMardSAAhangarpourABadaviM. The renoprotective effects of naringin and trimetazidine on renal ischemia/reperfusion injury in rats through inhibition of apoptosis and downregulation of micoRNA-10a. Biomed Pharmacother2019;112:108568. doi:10.1016/j.biopha.2019.01.029Open DOISearch in Google Scholar
Galati G, Chan T, Wu B, O’Brien PJ. Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redoxcycling of flavonoids. Chem Res Toxicol 1999;12:521–525. doi: 10.1021/tx980271bGalatiGChanTWuBO’BrienPJ. Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redoxcycling of flavonoids. Chem Res Toxicol1999;12:521–525. doi: 10.1021/tx980271bOpen DOISearch in Google Scholar